ClinicalTrials.govpublic full text
Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)
ovarian cancer, platinum resistant ovarian cancer, ttfields, paclitaxel, minimal toxicity, ttf, tumor treating fields, novocure, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 841062
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.